Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years

被引：0
|
作者：
Charles Oo
George Hill
Albert Dorr
Baolian Liu
Samuel Boellner
Penelope Ward
机构：
[1] Roche Global Development,
[2] Aventis Pharmaceutical Inc. 1041,undefined
[3] Roche Global Development,undefined
[4] XIQ Coordination Inc.,undefined
[5] Clinical Study Center,undefined
[6] Roche Global Development,undefined
来源：
European Journal of Clinical Pharmacology | 2003年 / 59卷
关键词：
Oseltamivir; Children;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：411 / 415
页数：4
相关论文
共 50 条
  • [1] Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years
    Oo, C
    Hill, G
    Dorr, A
    Liu, B
    Boellner, S
    Ward, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (5-6) : 411 - 415
  • [2] Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate
    Jin Soo Shin
    Keun Bon Ku
    Yejin Jang
    Yi-Seul Yoon
    Daeho Shin
    Oh Seung Kwon
    Yun Young Go
    Seong Soon Kim
    Myoung Ae Bae
    Meehyein Kim
    Journal of Microbiology, 2017, 55 : 979 - 983
  • [3] Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate
    Shin, Jin Soo
    Ku, Keun Bon
    Jang, Yejin
    Yoon, Yi-Seul
    Shin, Daeho
    Kwon, Oh Seung
    Go, Yun Young
    Kim, Seong Soon
    Bae, Myoung Ae
    Kim, Meehyein
    JOURNAL OF MICROBIOLOGY, 2017, 55 (12) : 979 - 983
  • [4] Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirin
    Oo, C
    Barrett, J
    Dorr, A
    Liu, BL
    Ward, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 1993 - 1995
  • [5] Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsules
    Oo, C
    Snell, P
    Barrett, J
    Dorr, A
    Liu, BL
    Wilding, I
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 257 (1-2) : 297 - 299
  • [6] Oseltamivir Pharmacokinetics, Dosing, and Resistance Among Children Aged <2 Years With Influenza
    Kimberlin, David W.
    Acosta, Edward P.
    Prichard, Mark N.
    Sanchez, Pablo J.
    Ampofo, Krow
    Lang, David
    Ashouri, Negar
    Vanchiere, John A.
    Abzug, Mark J.
    Abughali, Nazha
    Caserta, Mary T.
    Englund, Janet A.
    Sood, Sunil K.
    Spigarelli, Michael G.
    Bradley, John S.
    Lew, Judy
    Michaels, Marian G.
    Wan, Wen
    Cloud, Gretchen
    Jester, Penelope
    Lakeman, Fred D.
    Whitley, Richard J.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (05): : 709 - 720
  • [7] Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel
    Shi, Deshi
    Yang, Jian
    Yang, Dongfang
    LeCluyse, Edward L.
    Black, Chris
    You, Li
    Akhlaghi, Fatemeh
    Yan, Bingfang
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03): : 1477 - 1484
  • [8] Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids
    Snell, P
    Oo, C
    Dorr, A
    Barrett, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 372 - 377
  • [9] Comments on "Anti-Influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel"
    Fowler, Stephen
    Lennon, Sian M.
    Hoffmann, Gerhard
    Rayner, Craig R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (01): : 422 - 423
  • [10] Development of Oseltamivir Phosphonate Congeners as Anti-influenza Agents
    Cheng, Ting-Jen R.
    Weinheimer, Steven
    Tarbet, E. Bart
    Jan, Jia-Tsrong
    Cheng, Yih-Shyun E.
    Shie, Jiun-Jie
    Chen, Chun-Lin
    Chen, Chih-An
    Hsieh, Wei-Che
    Huang, Pei-Wei
    Lin, Wen-Hao
    Wang, Shi-Yun
    Fang, Jim-Min
    Hu, Oliver Yoa-Pu
    Wong, Chi-Huey
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (20) : 8657 - 8670
12345